The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia is a Strong Predictor for Survival

被引：0

作者：

Yilmaz, Musa ^{[1
]}

Kantarjian, Hagop ^{[1
]}

Wang, Xuemei ^{[2
]}

Loghavi, Sanam ^{[3
]}

Khoury, Joseph ^{[3
]}

Jorgensen, Jeffrey ^{[3
]}

Ravandi, Farhad ^{[1
]}

Short, Nicholas ^{[1
]}

Cortes, Jorge ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Kadia, Tapan ^{[1
]}

Sasaki, Koji ^{[1
]}

Konopleva, Marina ^{[1
]}

Takahashi, Koichi ^{[1
]}

Wierda, William ^{[1
]}

Khouri, Maria ^{[1
]}

Jain, Nitin ^{[1
]}

Verstovsek, Srdan ^{[1
]}

Estrov, Zeev ^{[1
]}

Bose, Prithviraj ^{[1
]}

Pierce, Sherry ^{[1
]}

Garris, Rebecca ^{[1
]}

O'Brien, Susan ^{[4
]}

Jabbour, Elias ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷

关键词：

minimal residual disease; ALL; survival; early; acute lymphoblastic leukemia;

D O I：

10.1016/j.clml.2019.07.040

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ALL-280

引用

页码：S193 / S194

页数：2

共 50 条

[31] Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy
Zhiyu Liu
Yang Li
Ce Shi
International Journal of Hematology, 2021, 113 : 337 - 343
[32] Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy
Liu, Zhiyu
Li, Yang
Shi, Ce
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 337 - 343
[33] ROLE OF MEASURABLE RESIDUAL DISEA SE QUANTIFIED BY MULTIPARAMETRIC FLOW CYTOMETRY BEFORE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGHRISK PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Kanoun, Rimmel Yosra
Mekni, Sabrine
Ben Abdeljelil, Nour
Ouerghi, Rihab
Ben Yaiche, Insaf
Turki, Ines
Ladeb, Saloua
Torjmane, Lamia
Belloumi, Dorra
Safra, Ines
Ben Othman, Tarek
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 473 - 474
[34] Achievement of Minimal Residual Disease Negativity By Multiparameter Flow Cytometry Is an Important Therapeutic Endpoint in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Salvage Treatment
Short, Nicholas J.
Kantarjian, Hagop M.
Jorgensen, Jeffrey L.
Ravandi, Farhad
Yilmaz, Musa
Khouri, Maria R.
Wang, Sa
Thomas, Deborah A.
Khoury, Joseph D.
Champlin, Richard E.
Khouri, Issa F.
Kebriaei, Partow
Marin, David
O'Brien, Susan M.
Garcia-Manero, Guillermo
Cortes, Jorge E.
Sasaki, Koji
DiNardo, Courtney D.
Kadia, Tapan M.
Jain, Nitin
Konopleva, Marina
Garris, Rebecca
Jabbour, Elias J.
BLOOD, 2016, 128 (22)
[35] High-dose of daunorubicin as induction treatment for adults with newly diagnosed Philadelphia-negative acute lymphoblastic leukemia.
Lee, S.
Joo, Y.
Lee, K.
Kim, K.
Ahn, J.
Sohn, S.
Kim, H.
Choi, Y.
Park, J.
Lee, G.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[36] Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Hoffmann, Alexander P.
Besch, Ashley L.
Othus, Megan
Morsink, Linde M.
Wood, Brent L.
Mielcarek, Marco
Estey, Elihu H.
Appelbaum, Frederick R.
Walter, Roland B.
BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 669 - 672
[37] Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Alexander P. Hoffmann
Ashley L. Besch
Megan Othus
Linde M. Morsink
Brent L. Wood
Marco Mielcarek
Elihu H. Estey
Frederick R. Appelbaum
Roland B. Walter
Bone Marrow Transplantation, 2020, 55 : 669 - 672
[38] Achievement of Measurable Residual Disease (MRD) Negativity Supersedes Treatment Intensity in Predicting the Outcome of Patients with Acute Myeloid Leukemia
Bazinet, Alexandre
Kadia, Tapan M.
Short, Nicholas
Borthakur, Gautam
Wang, Sa A.
Loghavi, Sanam
Jorgensen, Jeffrey L.
Patel, Keyur P.
DiNardo, Courtney D.
Daver, Naval
Alvarado, Yesid
Haddad, Fadi
Pierce, Sherry A.
Nogueras Gonzalez, Graciela M.
Maiti, Abhishek
Andreeff, Michael
Jabbour, Elias
Konopleva, Marina
Huang, Xuelin
Kantarjian, Hagop
Ravandi, Farhad
BLOOD, 2022, 140 : 2267 - 2269
[39] Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia
Della Starza, Irene
De Novi, Lucia A.
Santoro, Alessandra
Salemi, Domenico
Spinelli, Orietta
Tosi, Manuela
Soscia, Roberta
Paoloni, Francesca
V. Cappelli, Luca V.
Cavalli, Marzia
Apicella, Valerio
Bellomarino, Vittorio
Di Lello, Eleonora
Vitale, Antonella
Vignetti, Marco
Fabbiano, Francesco
Rambaldi, Alessandro
Bassan, Renato
Guarini, Anna
Chiaretti, Sabina
Foa, Robin
JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (08): : 893 - 900
[40] Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study
Leotta, Salvatore
Duminuco, Andrea
Mule, Antonino
Tringali, Stefania
Mauro, Elisa
Vetro, Calogero
Maugeri, Cinzia
Parisi, Marina
Garibaldi, Bruno
Di Renzo, Nicola
Romano, Claudia
Pastore, Domenico
Gentile, Massimo
Vigna, Ernesto
Selleri, Carmine
Milone, Giuseppe
Markovic, Uros
BLOOD, 2022, 140 : 11854 - 11855

← 1 2 3 4 5 →